(Q52573358)
Statements
Evaluations of vascular disrupting agents CA4P and OXi4503 in renal cell carcinoma (Caki-1) using a silicon based microvascular casting technique. (English)
Howard W Salmon
Christopher Mladinich
Dietmar W Siemann
7 September 2006
42
17
3073-3078